These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 25931836)

  • 21. Breast Imaging-Reporting and Data System (BI-RADS) classification in 51 excised palpable pediatric breast masses.
    Koning JL; Davenport KP; Poole PS; Kruk PG; Grabowski JE
    J Pediatr Surg; 2015 Oct; 50(10):1746-50. PubMed ID: 25783351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ultrasound Imaging Characteristics of Breast Lesions Diagnosed During Pregnancy and Lactation.
    Qian Y; Chang C; Zhang H
    Breastfeed Med; 2019 Dec; 14(10):712-717. PubMed ID: 31539269
    [No Abstract]   [Full Text] [Related]  

  • 23. Is duct excision still necessary for all cases of suspicious nipple discharge?
    Sabel MS; Helvie MA; Breslin T; Curry A; Diehl KM; Cimmino VM; Chang AE; Newman LA
    Breast J; 2012; 18(2):157-62. PubMed ID: 22211878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Magnetic resonance imaging of the breast as a problem-solving method: to be or not to be?
    Oztekin PS; Kosar PN
    Breast J; 2014; 20(6):622-31. PubMed ID: 25200378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retroareolar masses and intraductal abnormalities detected on screening ultrasound: can biopsy be avoided?
    Guo Y; Raghu M; Durand M; Hooley R
    Br J Radiol; 2018 Oct; 91(1090):20170816. PubMed ID: 29338316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of Mastalgia.
    ElSherif A; Valente SA
    Surg Clin North Am; 2022 Dec; 102(6):929-946. PubMed ID: 36335929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reassessment and Follow-Up Results of BI-RADS Category 3 Lesions Detected on Screening Breast Ultrasound.
    Chae EY; Cha JH; Shin HJ; Choi WJ; Kim HH
    AJR Am J Roentgenol; 2016 Mar; 206(3):666-72. PubMed ID: 26901026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Data as an Adjunct to Ultrasound Reduces the False-Negative Malignancy Rate in BI-RADS 3 Breast Lesions.
    Ackermann S; Schoenenberger CA; Zanetti-Dällenbach R
    Ultrasound Int Open; 2016 Sep; 2(3):E83-9. PubMed ID: 27689181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of Matricaria chamomilla (chamomile) extract on pain control of cyclic mastalgia: a double-blind randomised controlled trial.
    Saghafi N; Rhkhshandeh H; Pourmoghadam N; Pourali L; Ghazanfarpour M; Behrooznia A; Vafisani F
    J Obstet Gynaecol; 2018 Jan; 38(1):81-84. PubMed ID: 29072514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of mammography sensitivity after reduction mammoplasty targeting the glandular and fat tissue.
    Çakır M; Küçükkartallar T; Tekin A; Selimoğlu N; Poyraz N; Belviranlı MM; Kartal A
    Ulus Cerrahi Derg; 2015; 31(2):68-71. PubMed ID: 26170752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is a one-year follow-up an efficient method for better management of MRI BI-RADS(®) 3 lesions?
    Boisserie-Lacroix M; Ziadé C; Hurtevent-Labrot G; Ferron S; Brouste V; Lippa N
    Breast; 2016 Jun; 27():1-7. PubMed ID: 27212693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Accuracy of classification of breast ultrasound findings based on criteria used for BI-RADS.
    Heinig J; Witteler R; Schmitz R; Kiesel L; Steinhard J
    Ultrasound Obstet Gynecol; 2008 Sep; 32(4):573-8. PubMed ID: 18421795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of fructus agni casti and flurbiprofen in the treatment of cyclic mastalgia in premenopausal women.
    Dinç T; Coşkun F
    Ulus Cerrahi Derg; 2014; 30(1):34-8. PubMed ID: 25931888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of malignancy in palpable solid breast masses considered probably benign or low suspicion: implications for management.
    Giess CS; Smeglin LZ; Meyer JE; Ritner JA; Birdwell RL
    J Ultrasound Med; 2012 Dec; 31(12):1943-9. PubMed ID: 23197547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Papillary lesions initially diagnosed at ultrasound-guided vacuum-assisted breast biopsy: rate of malignancy based on subsequent surgical excision.
    Chang JM; Han W; Moon WK; Cho N; Noh DY; Park IA; Jung EJ
    Ann Surg Oncol; 2011 Sep; 18(9):2506-14. PubMed ID: 21369740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characteristics, Malignancy Rate, and Follow-up of BI-RADS Category 3 Lesions Identified at Breast MR Imaging: Implications for MR Image Interpretation and Management.
    Chikarmane SA; Birdwell RL; Poole PS; Sippo DA; Giess CS
    Radiology; 2016 Sep; 280(3):707-15. PubMed ID: 27089027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeted ultrasound in women younger than 30 years with focal breast signs or symptoms: outcomes analyses and management implications.
    Loving VA; DeMartini WB; Eby PR; Gutierrez RL; Peacock S; Lehman CD
    AJR Am J Roentgenol; 2010 Dec; 195(6):1472-7. PubMed ID: 21098212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pregnancy related breast diseases in a developing African country: Initial Sonographic Evaluation.
    Adeniji-Sofoluwe AT; Obajimi GO; Obajimi MO
    Pan Afr Med J; 2015; 20():239. PubMed ID: 27386035
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Rare Clinical Entity in the Differential Diagnosis of Mastalgia: Thoracic Zona.
    Özkan Z; Kanat BH; Gönen AN; Kanat Z; Buğra BM
    J Breast Health; 2015 Oct; 11(4):168-171. PubMed ID: 28331716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.